289 related articles for article (PubMed ID: 33882866)
1. C3 glomerulonephritis associated with ANCA positivity: a case report.
Li L; Liu LQ; Yang YY; Hu ZX
BMC Nephrol; 2021 Apr; 22(1):143. PubMed ID: 33882866
[TBL] [Abstract][Full Text] [Related]
2. Clinico-pathologic spectrum of C3 glomerulopathy-an Indian experience.
Viswanathan GK; Nada R; Kumar A; Ramachandran R; Rayat CS; Jha V; Sakhuja V; Joshi K
Diagn Pathol; 2015 Mar; 10():6. PubMed ID: 25889427
[TBL] [Abstract][Full Text] [Related]
3. C3 glomerulonephritis with a severe crescentic phenotype.
Ravindran A; Fervenza FC; Smith RJH; Sethi S
Pediatr Nephrol; 2017 Sep; 32(9):1625-1633. PubMed ID: 28593446
[TBL] [Abstract][Full Text] [Related]
4. Myeloperoxidase Antineutrophil Cytoplasmic Antibody (MPO-ANCA) Associated Crescentic and Necrotizing Glomerulonephritis (GN) with Membranoproliferative GN Features.
Koda R; Nagahori K; Kitazawa A; Imanishi Y; Yoshino A; Kawamoto S; Ueda Y; Takeda T
Intern Med; 2016; 55(15):2043-8. PubMed ID: 27477412
[TBL] [Abstract][Full Text] [Related]
5. [Case of MPO-ANCA-associated vasculitis with membranous nephropathy].
Watanabe S; Arimura Y; Nomura K; Kawashima S; Yoshihara K; Kaname S; Yamada A
Nihon Jinzo Gakkai Shi; 2011; 53(1):46-52. PubMed ID: 21370577
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E is enriched in dense deposits and is a marker for dense deposit disease in C3 glomerulopathy.
Madden B; Singh RD; Haas M; Palma LMP; Sharma A; Vargas MJ; Gross L; Negron V; Nate T; Charlesworth MC; Theis JD; Nasr SH; Nath KA; Fervenza FC; Sethi S
Kidney Int; 2024 May; 105(5):1077-1087. PubMed ID: 38447879
[TBL] [Abstract][Full Text] [Related]
7. Glomerular Immune Deposition in MPO-ANCA Associated Glomerulonephritis Is Associated With Poor Renal Survival.
Lin W; Shen C; Zhong Y; Ooi JD; Eggenhuizen P; Zhou YO; Luo H; Huang J; Chen JB; Wu T; Meng T; Xiao Z; Ao X; Peng W; Tang R; Yin H; Xiao X; Zhou Q; Xiao P
Front Immunol; 2021; 12():625672. PubMed ID: 33841408
[TBL] [Abstract][Full Text] [Related]
8. C3 glomerulopathy: clinicopathologic features and predictors of outcome.
Medjeral-Thomas NR; O'Shaughnessy MM; O'Regan JA; Traynor C; Flanagan M; Wong L; Teoh CW; Awan A; Waldron M; Cairns T; O'Kelly P; Dorman AM; Pickering MC; Conlon PJ; Cook HT
Clin J Am Soc Nephrol; 2014 Jan; 9(1):46-53. PubMed ID: 24178974
[TBL] [Abstract][Full Text] [Related]
9. A case presenting with the possible relationship between myeloperoxidase-antineutrophil cytoplasmic antibody-associated glomerulonephritis and membranous changes of the glomerular basement membrane.
Uyama S; Ohashi N; Iwakura T; Ono M; Fujikura T; Sakao Y; Yasuda H; Kato A; Fujigaki Y
CEN Case Rep; 2013 May; 2(1):53-58. PubMed ID: 28509220
[TBL] [Abstract][Full Text] [Related]
10. A case of myeloperoxidase anti-neutrophil cytoplasmic antibody (MPO-ANCA)-associated glomerulonephritis and concurrent membranous nephropathy.
Shimada M; Fujita T; Nakamura N; Narita I; Shimaya Y; Murakami R; Yamabe H; Osawa H; Okumura K
BMC Nephrol; 2013 Mar; 14():73. PubMed ID: 23537120
[TBL] [Abstract][Full Text] [Related]
11. De novo C3 glomerulonephritis in a renal allograft.
Nahm JH; Song SH; Kim YS; Cheong HI; Lim BJ; Kim BS; Jeong HJ
Ultrastruct Pathol; 2016; 40(2):112-5. PubMed ID: 26986539
[TBL] [Abstract][Full Text] [Related]
12. Membranous nephropathy with crescents: a series of 19 cases.
Rodriguez EF; Nasr SH; Larsen CP; Sethi S; Fidler ME; Cornell LD
Am J Kidney Dis; 2014 Jul; 64(1):66-73. PubMed ID: 24709471
[TBL] [Abstract][Full Text] [Related]
13. Antineutrophil cytoplasmic antibody-associated crescentic glomerulonephritis with membranous nephropathy treated using thiamazole.
Kakita T; Nagatoya K; Takimoto H; Matsuda H; Mori T; Kawaguchi A; Inoue T
CEN Case Rep; 2013 Nov; 2(2):165-169. PubMed ID: 28509295
[TBL] [Abstract][Full Text] [Related]
14. C3 glomerulonephritis and dense deposit disease share a similar disease course in a large United States cohort of patients with C3 glomerulopathy.
Bomback AS; Santoriello D; Avasare RS; Regunathan-Shenk R; Canetta PA; Ahn W; Radhakrishnan J; Marasa M; Rosenstiel PE; Herlitz LC; Markowitz GS; D'Agati VD; Appel GB
Kidney Int; 2018 Apr; 93(4):977-985. PubMed ID: 29310824
[TBL] [Abstract][Full Text] [Related]
15. ANCA-associated crescentic glomerulonephritis with mesangial IgA deposits.
Haas M; Jafri J; Bartosh SM; Karp SL; Adler SG; Meehan SM
Am J Kidney Dis; 2000 Oct; 36(4):709-18. PubMed ID: 11007672
[TBL] [Abstract][Full Text] [Related]
16. Membranous glomerulonephritis with ANCA-associated necrotizing and crescentic glomerulonephritis.
Nasr SH; Said SM; Valeri AM; Stokes MB; Masani NN; D'Agati VD; Markowitz GS
Clin J Am Soc Nephrol; 2009 Feb; 4(2):299-308. PubMed ID: 19158367
[TBL] [Abstract][Full Text] [Related]
17. [Rapidly progressive proliferative glomerulonephritis with monoclonal immunoglobulin G deposits despite the mild histological changes. Case report].
Bajcsi D; Constantinou K; Krenács L; Barabás Z; Molnár S; Nyiraty S; Ábrahám G; Iványi B
Orv Hetil; 2018 Sep; 159(38):1567-1572. PubMed ID: 30227733
[TBL] [Abstract][Full Text] [Related]
18. Development of anti-glomerular basement membrane glomerulonephritis during the course of IgA nephropathy: a case report.
Kojima T; Hirose G; Komatsu S; Oshima T; Sugisaki K; Tomiyasu T; Yoshikawa N; Yamada M; Oda T
BMC Nephrol; 2019 Jan; 20(1):25. PubMed ID: 30683055
[TBL] [Abstract][Full Text] [Related]
19. C3 glomerulopathy.
Servais A; Noël LH; Frémeaux-Bacchi V; Lesavre P
Contrib Nephrol; 2013; 181():185-93. PubMed ID: 23689580
[TBL] [Abstract][Full Text] [Related]
20. Rare case of exostosin 1/exostosin 2-related membranous lupus nephritis concomitant with dual ANCA- and anti-GBM antibody-associated crescentic glomerulonephritis effectively diagnosed by mass spectrometry: a case report.
Yamazaki T; Takahashi H; Takeuchi K; Sakamoto E; Tominaga K; Sakurabayashi S; Abe T; Sano T; Wada Y; Kuwahara N; Shimizu A; Takeuchi Y
BMC Nephrol; 2023 Jul; 24(1):218. PubMed ID: 37488532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
